Skip to content


  • Oral presentation
  • Open Access

High prevalence of cytomegalovirus (CMV) infection in infants born to HIV infected mothers–ANRS French Perinatal Cohort (EPF)

  • 1,
  • 2, 3,
  • 2, 3,
  • 4, 5,
  • 1, 6, 7,
  • 3, 8,
  • 1, 9,
  • 1, 10,
  • 1, 9,
  • 1, 9, 10, 11 and
Retrovirology20085 (Suppl 1) :O10

  • Published:


  • Sensorineural Hearing
  • Sensorineural Hearing Loss
  • Central Nervous System Disease
  • Nervous System Disease
  • Infected Mother


In developed countries, 0.3% to 0.5% of all newborns are congenitally infected by cytomegalovirus (CMV) with the risk of sensorineural hearing loss or mental retardation [1, 2]. Few results about congenital CMV infection in infants born to HIV-infected women have been reported [3]. Rate of disease progression and central nervous system disease was found to be higher in HIV-1-infected infants who acquire CMV infection in the first 18 months of life than those infected with HIV-1 alone [4]. We aimed to estimate the prevalence of neonatal CMV infection in children born to HIV-infected mothers between 1993 and 2004 enrolled in the ANRS French Perinatal Cohort (EPF).

Materials and methods

EPF is a national prospective multicenter cohort of mother-to-child HIV transmission. As part of the standardized follow-up of infants born alive between 1993 and 2004 in EPF sites, a urine sample was obtained within the ten first days of life. These samples were used to screen for congenital CMV infection, using rapid culture from 1993 to 2001 and real-time PCR since 2001.


Between 1993 and 2004, 4995 of the 7878 newborns included in EPF were screened for CMV. The prevalence of CMV infection was 2.4% (119 positive tests; 95% confidence interval: 2.0–2.8). Thirteen of the 119 CMV infected newborns were also infected with HIV. The prevalence of CMV infection was higher in HIV-infected newborns (10.2%; 95% CI: 4.9-15.5) than in HIV-uninfected newborns (2.2%, 95% CI: 1.8-2.6, p<0.01).


The prevalence of congenital CMV infection was high in children born to HIV- infected mothers and was significantly higher in HIV-infected children than HIV-uninfected children.



The study was supported by the ANRS. We thank all cohort investigators and V Benhammou, N Chernai, A Diop, K Hamrene, P Huynh, C Laurent, M Peres, ERamos, L Boufassa, T Wack, N Zeller.

Authors’ Affiliations

Inserm, U822, Le Kremlin-Bicêtre, France, F-94276
AP-HP, Virology Department, Necker Hospital, Paris, F-75015, France
EA 3620, Univ Paris Descartes 5, Paris, France
AP-HP, Department of infectious diseases, Hôpital Pitié Salpêtrière, Paris, F-75651, France
INSERM, U543, Paris, France
Univ Paris 7, Paris, France
AP-HP, Gynecology and obstetrics department, Hôpital Louis Mourrier, Colombes, France, F-92700
AP-HP, Unité d'Immunologie Hématologie Pédiatrique, Necker Hospital, Paris, France, F-75015
INED, Paris, France, F-75020
AP-HP, Epidemiology department, Hopital Bicêtre, Le Kremlin-Bicêtre, France, F-94276
Univ Paris-Sud, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France, F-94276


  1. Barbi M, Binda S, Caroppo S, Calvario A, Germinario C, Bozzi A, et al: Multicity Italian study of congenital cytomegalovirus infection. Pediatr Infect Dis J. 2006, 25: 156-159. 10.1097/01.inf.0000199261.98769.29.View ArticlePubMedGoogle Scholar
  2. Gratacap-Cavallier B, Morand P, Dutertre N, Bosson JL, Baccard-Longere M, Jouk PS, et al: Cytomegalovirus infection in pregnant women. Seroepidemiological prospective study in 1,018 women in Isere. J Gynecol Obstet Biol Reprod (Paris). 1998, 27: 161-166.Google Scholar
  3. Doyle M, Atkins JT, Rivera-Matos IR: Congenital cytomegalovirus infection in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996, 15: 1102-1106. 10.1097/00006454-199612000-00010.View ArticlePubMedGoogle Scholar
  4. Kovacs A, Schluchter M, Easley K, Demmler G, Shearer W, La Russa P, et al: Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med. 1999, 341: 77-84. 10.1056/NEJM199907083410203.PubMed CentralView ArticlePubMedGoogle Scholar


© Guibert et al.; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd.